Zobrazeno 1 - 10
of 154
pro vyhledávání: '"malignant plasma cells"'
Autor:
Jayeeta Ghose, Ada Dona, Mariam Murtadha, Emine Gulsen Gunes, Enrico Caserta, Ji Young Yoo, Luke Russell, Alena Cristina Jaime-Ramirez, Benjamin G. Barwick, Vikas A. Gupta, James F. Sanchez, Douglas W. Sborov, Steven T. Rosen, Amrita Krishnan, Lawrence H. Boise, Balveen Kaur, Craig C. Hofmeister, Flavia Pichiorri
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 519-531 (2021)
Because most patients with multiple myeloma (MM) develop resistance to current regimens, novel approaches are needed. Genetically modified, replication-competent oncolytic viruses exhibit high tropism for tumor cells regardless of cancer stage and pr
Externí odkaz:
https://doaj.org/article/65d17a0839584df484a779e3dc1740bf
Autor:
Stefan Forster, Ramin Radpour
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Multiple myeloma (MM) is the most common malignant monoclonal disease of plasma cells. Aside from classical chemotherapy and glucocorticoids, proteasome inhibitors, immunomodulatory agents and monoclonal antibodies are used in the current treatment s
Externí odkaz:
https://doaj.org/article/902628d05e784dd7bc01dcee609d6239
Autor:
Vikas Gupta, Balveen Kaur, James F. Sanchez, Luke Russell, Ji Young Yoo, Steven T. Rosen, Alena Cristina Jaime-Ramirez, Enrico Caserta, Ada Dona, Jayeeta Ghose, Amrita Krishnan, Douglas W. Sborov, Emine Gulsen Gunes, Benjamin G. Barwick, Flavia Pichiorri, Mariam Murtadha, Lawrence H. Boise, Craig C. Hofmeister
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss, Pp 519-531 (2021)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
Because most patients with multiple myeloma (MM) develop resistance to current regimens, novel approaches are needed. Genetically modified, replication-competent oncolytic viruses exhibit high tropism for tumor cells regardless of cancer stage and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa1b0ab1a752ab3249d99985fbbbc36b
http://www.sciencedirect.com/science/article/pii/S2372770521000279
http://www.sciencedirect.com/science/article/pii/S2372770521000279
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Bone Oncology, Vol 15, Iss, Pp-(2019)
Journal of Bone Oncology
Journal of Bone Oncology
Highlights • Bone metastases negatively impact on patients’ quality of life (QoL). • Skeletal related events have a detrimental effect on both QoL and survival. • Both local and systemic treatments are often required to manage bone metastases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::800cf502ba8951ee91fa265eeba1e16b
http://www.sciencedirect.com/science/article/pii/S2212137418302586
http://www.sciencedirect.com/science/article/pii/S2212137418302586
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Craig, Jenny I. O., author
Publikováno v:
Palliative Care Consultations in Haemato-oncology, 2003, ill.
Externí odkaz:
https://doi.org/10.1093/acprof:oso/9780198528081.003.0001
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 9, Iss 3, Pp 296-301 (2016)
Aim. To analyze the relationship between expression of aberrant CD45, CD19, CD56 markers on the plasma cells and clinical and laboratory findings and prognostically significant parameters in patients with multiple myeloma (MM). Methods. This scientif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75b11ba3b199fcd0d1744b246b03ee70
https://doi.org/10.21320/2500-2139-2016-9-3-296-301
https://doi.org/10.21320/2500-2139-2016-9-3-296-301
Publikováno v:
Molecular medicine, 17(7-8), 790-798. FEINSTEIN INST MED RES
Molecular Medicine, 17(7-8), 790-798. Feinstein Institute for Medical Research
Molecular Medicine, 17(7-8), 790-798. Feinstein Institute for Medical Research
Multiple myeloma (MM) is a neoplasm of plasma cell origin that is largely confined to the bone marrow (BM). Chromosomal translocations and other genetic events are known to contribute to deregulation of signaling pathways that lead to transformation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::015ec506f9c6aefa9909703ac7e3a328
https://doi.org/10.2119/molmed.2011.00013
https://doi.org/10.2119/molmed.2011.00013